By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Cell Source, Inc.

Cell Source, Inc. (CLCS)

OTC Currency in USD
$0.41
+$0.02
+5.13%
Last Update: 29 Aug 2025, 19:50
$17.82M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.14 - $0.84
52 Week Range

CLCS Stock Price Chart

Explore Cell Source, Inc. interactive price chart. Choose custom timeframes to analyze CLCS price movements and trends.

CLCS Company Profile

Discover essential business fundamentals and corporate details for Cell Source, Inc. (CLCS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

1 May 2014

Employees

1.00

CEO

Itamar Shimrat

Description

Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York.

CLCS Financial Timeline

Browse a chronological timeline of Cell Source, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 Nov 2025

Earnings released on 23 Jun 2025

Earnings released on 14 Nov 2024

EPS came in at -$0.03 .

Earnings released on 19 Aug 2024

EPS came in at -$0.04 .

Earnings released on 29 Jul 2024

EPS came in at -$0.03 .

Earnings released on 24 Jun 2024

EPS came in at -$0.03 .

Earnings released on 9 Nov 2023

EPS came in at -$0.04 .

Earnings released on 19 Sept 2023

EPS came in at -$0.03 .

Earnings released on 23 Aug 2023

EPS came in at -$0.05 .

Earnings released on 8 Aug 2023

EPS came in at -$0.04 .

Earnings released on 8 Dec 2022

EPS came in at -$0.04 .

Earnings released on 2 Dec 2022

EPS came in at -$0.04 .

Earnings released on 2 Nov 2022

EPS came in at -$0.04 .

Earnings released on 15 Apr 2022

EPS came in at -$0.03 .

Earnings released on 15 Nov 2021

EPS came in at -$0.05 .

Earnings released on 12 Aug 2021

EPS came in at -$0.04 .

Earnings released on 17 May 2021

EPS came in at -$0.05 .

Earnings released on 15 Apr 2021

EPS came in at -$0.04 .

Earnings released on 13 Nov 2020

EPS came in at -$0.04 .

CLCS Stock Performance

Access detailed CLCS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run